Cofactor Genomics
Cofactor Genomics builds multidimensional models of disease to deliver true precision medicine.
About Cofactor Genomics
Cofactor Genomics is a company focused on predictive immune modeling. They aim to advance precision medicine by overcoming existing barriers. Cofactor facilitates the shift from single-analyte biomarkers to more comprehensive multidimensional biomarkers using health expression models. Their capabilities include molecular, informatic, and database tools, with one of the first CAP-certified clinical RNA sequencing laboratories. This certification helps their partners conduct clinical trials more efficiently and cost-effectively. Their expertise in molecular biology, informatics, and database management enables them to provide high-quality services to the healthcare and pharmaceutical sectors, contributing to medical research and improving patient outcomes.
Company Facts
- Headquarters
- San Francisco
- Operating Status
- active
- Company Type
- for_profit
- IPO Status
- private
- Employees
- c_00011_00050
- Total Funding
- $29,031,394
- Last Funding Type
- series_unknown
- Last Funding Date
- 2025-12-15
- Website
- cofactorgenomics.com
Industries & Categories
Biotechnology, Clinical Trials, Genetics, Health Care, Health Diagnostics, Precision Medicine
Social Links
Canonical: https://fsome.com/organization/cofactor-genomics-57080 · For the full interactive profile (funding rounds, investors, team, portfolio, charts), please enable JavaScript.